ProCE Banner Activity

Interactive Tool to Guide Management of Adverse Events With BTK Inhibitor Therapy in Hematologic Malignancies

Tool

Use this Interactive Decision Support Tool to learn strategies to assess and manage adverse events associated with BTK inhibitors from international experts in managing patients with hematologic malignancies.

Released: January 07, 2025

Expiration: January 06, 2026

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca

Disclosure

Primary Author

Toby A Eyre, MBChB, MD

Hematology Consultant
Honorary Senior Lecturer at the University of Oxford
Oxford University Hospitals NHS Trust
Oxford, United Kingdom

Toby A. Eyre, MBChB, MD: consultant/advisor/speaker: AbbVie, AstraZeneca, Autolus, BeiGene, Bristol Myers Squibb, Galapagos, Gilead, Incyte, Janssen, Kite, Loxo Oncology, Roche; researcher: AstraZeneca, BeiGene, Gilead.

Arnon Kater, MD, PhD

Professor of Hematology
Deputy Head of Department
Chairman, HOVON CLL Working Group and President, HOVON Executive Board
Department of Hematology
Lymphoma and Myeloma Research Amsterdam
Amsterdam, Netherlands

Arnon Kater, MD, MPH: advisor/speaker (paid to institution): AbbVie, Bristol Myers Squibb, Janssen, LAVA, Roche/Genentech; researcher (paid to institution): AbbVie, Bristol Myers Squibb, Janssen, Lilly, Roche/Genentech; patent (paid to institution): Janssen, LAVA.

Vincent Ribrag, MD

Hematology Department
Chief Molecular Therapeutics in Hematological Early Drug Development
Gustave Roussy
Villejuif, France

Vincent Ribrag, MD: consultant/advisor/speaker: AstraZeneca, Lilly; researcher: Astex, GSK; employee: Pegascy.

Stephan Stilgenbauer, MD

Medical Director, Comprehensive Cancer Center Ulm
Head, Early Clinical Trials Unit
Head, Division of CLL
Department of Internal Medicine III
Comprehensive Cancer Center Ulm
University Medical Center Ulm
Ulm, Germany

Stephan Stilgenbauer, MD: consultant/advisor/speaker: AbbVie, Amgen, AstraZeneca, BeiGene, Bristol Myers Squibb, Galapagos, Gilead, GlaxoSmithKline, Hoffmann-La Roche, Janssen, Lilly, Novartis, Sunesis.

Alessandra Tedeschi, MD

Medical Doctor
Department of Hematology
Niguarda Cancer Center Milano
Milano, Italy

Alessandra Tedeschi, MD: consultant/advisor/speaker: AbbVie, AstraZeneca, BeiGene, Johnson & Johnson, Lilly.